Back to Semaglutide research
semaglutide glp 1 agonist other 2025-04-18 ClinicalTrials

Novel Combination Therapy ASC47 with Semaglutide Explores Enhanced Obesity Treatment

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide

Abstract

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 Injection, for Subcutaneous Use in Combination With Semaglutide in Participants With Obesity NCT ID: NCT0…

semaglutide glp 1 agonist protocol relevant safety data present
Source: clinicaltrials:NCT06972992 · Ingested 2026-04-08 · Digest: gemini-2.5-flash